Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03098160
Title Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Threshold Pharmaceuticals

head and neck squamous cell carcinoma

prostate cancer


pancreatic cancer


Evofosfamide + Ipilimumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.